UAB "ORION PHARMA" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,937,912 |
322,985 |
144,953 |
110,909 |
18,485 |
7.40 |
5.72 |
617,626 |
92,890 |
0 |
804,356 |
2023 |
---|
1,557,627 |
180,281 |
130,690 |
111,435 |
12,898 |
7.41 |
7.15 |
328,625 |
239,126 |
0 |
585,928 |
2024 |
---|
1,580,272 |
154,173 |
125,943 |
101,185 |
9,872 |
7.40 |
6.40 |
159,809 |
62,034 |
0 |
309,649 |
Register and
explore Okredo data2024 |
---|
1,580,272 |
154,173 |
125,943 |
101,185 |
9,872 |
7.40 |
6.40 |
159,809 |
62,034 |
0 |
309,649 |
Register and
explore Okredo data2024
Turnover (€)
1,580,272 €1 % *
Sales per employee (€)
154,173 €-14 % *
Profit before tax (€)
125,943 €-4 % *
Net Profit (€)
101,185 €-9 % *
Profit per employee (€)
9,872 €-23 % *
Total profitability (%)
7.40 %-0.13 % *
Net profitability (%)
6.40 %-10.49 % *
Equity (€)
159,809 €-51 % *
Amounts Payable And Liabilities (€)
62,034 €-74 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
309,649 €-47 % *